The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Medical Properties Trust Inc

NYSE: MPW
Last

(U.S.) $9.86

Today's change-0.48 -4.64%
Updated February 11 4:01 PM EST. Delayed by at least 15 minutes.
 

Medical Properties Trust Inc

NYSE: MPW
Last

(U.S.) $9.86

Today's change-0.48 -4.64%
Updated February 11 4:01 PM EST. Delayed by at least 15 minutes.

Medical Properties Trust Inc down (U.S.)$0.48

Medical Properties Trust Inc closed sharply lower Thursday, dropping (U.S.)$0.48 or 4.64% to (U.S.)$9.86. Over the last five days, shares have lost 12.12% and sit 2.60% above their 52-week low. This security has underperformed the S&P 500 by 20.80% during the last year.

Key company metrics

  • Open(U.S.) $10.19
  • Previous close(U.S.) $10.34
  • High(U.S.) $10.21
  • Low(U.S.) $9.78
  • Bid / Ask(U.S.) $9.76 / (U.S.) $10.59
  • YTD % change-14.34%
  • Volume2,708,128
  • Average volume (10-day)1,860,440
  • Average volume (1-month)1,967,145
  • Average volume (3-month)2,101,474
  • 52-week range(U.S.) $9.61 to (U.S.) $15.48
  • Beta1.05
  • Trailing P/E16.10×
  • P/E 1 year forward10.14×
  • Forward PEG1.86×
  • Indicated annual dividend(U.S.) $0.88
  • Dividend yield8.92%
  • Trailing EPS(U.S.) $0.61
Updated February 11 4:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+31.67%

Based on its net profit margin of 31.67%, Medical Properties Trust Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.81%Sector:HealthcareIndustry:Healthcare Facilities

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue1151009682
Total other revenue--------
Total revenue1151009682
Gross profit--------
Total cost of revenue--------
Total operating expense57523245
Selling / general / administrative13111112
Research & development--------
Depreciation / amortization20151514
Interest expense (income), net operating--------
Unusual expense (income)2526618
Other operating expenses, total--------
Operating income57486437
Interest income (expense), net non-operating-36-27-27-28
Gain (loss) on sale of assets--------
Other--------
Income before tax23233615
Income after tax23223615
Income tax, total0100
Net income23223615
Total adjustments to net income0000
Net income before extra. items23223615
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items23223615
Inc. avail. to common incl. extra. items23223615
Diluted net income23223615
Dilution adjustment--------
Diluted weighted average shares224209204173
Diluted EPS excluding extraordinary itemsvalue per share0.100.110.170.08
Dividends per sharevalue per share0.220.220.220.21
Diluted normalized EPSvalue per share0.210.230.210.19